Safety, Tolerability, and Efficacy of RLS103 in Subjects With Acute Anxiety Within Social Anxiety Disorder (SAD)

Inclusion Criteria: * Must sign an informed consent form (ICF) indicating that they understand the purpose of the study and the procedures required for the study and are willing to participate in the study and attend all visits and requirements. * Male or female 18 through 65 years of age, inclusive. * Current diagnosis of SAD as defined in the MINI. * Clinician-rated LSAS total score ≥75 at Screening (Visit 1). * Clinician-rated Hamilton Depression Score 17-items total score \<18 at Screening (Visit 1). * Women of childbearing potential must commit to the consistent and correct use of an effective method of birth control throughout the study and must also have negative pregnancy test result at Screening (Visit 1), Baseline (Visit 2), and Visit 3. Effective methods of contraception include surgical sterilization of the subject, condoms with spermicide, diaphragm with spermicide, hormonal contraceptive agents (oral, transdermal, or injectable), or implantable contraceptive devices. * Body mass index (BMI) between 18 and 32 kg/m2 (inclusive) with a body weight ≥50 kg. * Non-smoker with no cigarettes, cigars, e-cigarettes, or nicotine-containing products used in the 1 month prior to Screening as confirmed by negative serum cotinine results (\<10 ng/mL) at Screening. * Negative viral serology test results (HIV-1/HIV-2, hepatitis B and C virus). * Must have no medical contraindication to CBD, including known allergies or hypersensitivities to CBD or the excipients in RLS103. * Mu…